Dr. Hughes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Fairfax Ave
Ste 610
Norfolk, VA 23507Phone+1 757-446-8960Fax+1 757-446-5197
Summary
- Dr. Marybeth Hughes is a surgical oncologist in Norfolk and is affiliated with Eastern Virginia Medical School. She received her medical degree from Eastern Virginia Medical School and has trained in general surgery. Her surgical oncology training was completed at the National Cancer Institute. She practiced at the National Institutes of health for 12 years prior to moving to Virginia. She has been in practice 16 years. She specializes in endocrine, hepatobiliary surgery, melanoma and other surgical oncology (non-breast), and sarcomas. She is also trained in minimally invasive techniques such as robotics.
Education & Training
- University of RochesterFellowship, Surgery, 2002 - 2004
- Eastern Virginia Medical SchoolResidency, Surgery, 1997 - 2002
- Eastern Virginia Medical SchoolClass of 1997
Certifications & Licensure
- VA State Medical License 1997 - 2026
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
Publications & Presentations
PubMed
- 859 citationsPhase 2 trial of single agent ipilimumab (Anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinomaRichard E. Royal, Catherine Levy, Keli Turner, Aarti Mathur, Marybeth Hughes
Journal of Immunotherapy. 2010-10-01 - 1058 citationsGene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James Chih-Hsin Yang
Blood. 2009-07-16 - 1954 citationsCancer regression in patients after transfer of genetically engineered lymphocytesRichard A. Morgan, Mark E. Dudley, John R. Wunderlich, Michael S. Hughes, James Chih-Hsin Yang
Science. 2006-10-06
Professional Memberships
- Member
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: